These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8415869)

  • 21. [D-Val22]big ET-1[16-38] inhibits endothelin-converting enzyme activity: a promising concept in the prevention of cerebral vasospasm.
    Zimmermann M; Jung CS; Vatter H; Raabe A; Seifert V
    Neurosurg Rev; 2003 May; 26(2):125-32. PubMed ID: 12962299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guinea pig Clara cells secrete endothelin 1 through a phosphoramidon-sensitive pathway.
    Laporte J; D'Orléans-Juste P; Sirois P
    Am J Respir Cell Mol Biol; 1996 Apr; 14(4):356-62. PubMed ID: 8600940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conversion of big ET-1 in the rat lung: role of phosphoramidon-sensitive endothelin-1-converting enzyme.
    Hisaki K; Matsumura Y; Maekawa H; Fujita K; Takaoka M; Morimoto S
    Am J Physiol; 1994 Feb; 266(2 Pt 2):H422-8. PubMed ID: 8141343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphoramidon treatment improves the consequences of chagasic heart disease in mice.
    Jelicks LA; Chandra M; Shtutin V; Petkova SB; Tang B; Christ GJ; Factor SM; Wittner M; Huang H; Douglas SA; Weiss LM; Orleans-Juste PD; Shirani J; Tanowitz HB
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():267S-271S. PubMed ID: 12193101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual endothelin-converting enzyme/neutral endopeptidase inhibition: a novel treatment for renovascular hypertension beyond blood pressure lowering?
    Dhaun N; Webb DJ
    Hypertension; 2011 Apr; 57(4):667-9. PubMed ID: 21339473
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of big ET-1-induced pressor response by an orally active dual inhibitor of endothelin-converting enzyme and neutral endopeptidase 24.11.
    Trapani AJ; De Lombaert S; Kuzmich S; Jeng AY
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S69-71. PubMed ID: 8587471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel therapy approach in primary stroke prevention: simultaneous inhibition of endothelin converting enzyme and neutral endopeptidase in spontaneously hypertensive, stroke-prone rats improves survival.
    Wengenmayer C; Krikov M; Mueller S; Lucht K; Villringer A; Hocher B; Unger T; Thoene-Reineke C
    Neurol Res; 2011 Mar; 33(2):201-7. PubMed ID: 21801596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure of human endothelin-converting enzyme I complexed with phosphoramidon.
    Schulz H; Dale GE; Karimi-Nejad Y; Oefner C
    J Mol Biol; 2009 Jan; 385(1):178-87. PubMed ID: 18992253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A simple method for isolating human endothelin converting enzyme free from contamination by neutral endopeptidase 24.11.
    Corder R; Khan N; Harrison VJ
    Biochem Biophys Res Commun; 1995 Feb; 207(1):355-62. PubMed ID: 7857289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphoramidon-sensitive endothelin-converting enzymes modulate cerebral blood flow and neural damage of hypoxic rats.
    Park L; Thornhill J
    Neurosci Lett; 2001 Mar; 301(2):95-8. PubMed ID: 11248431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual endothelin-converting enzyme/neutral endopeptidase blockade in rats with D-galactosamine-induced liver failure.
    Hocher B; Heiden S; von Websky K; Rahnenführe J; Kalk P; Pfab T
    Eur J Med Res; 2011 Jun; 16(6):275-9. PubMed ID: 21810562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of a selective neutral endopeptidase and a nonselective neutral endopeptidase/endothelin-converting enzyme inhibitor on lipopolysaccharide-induced endotoxaemia in anaesthetized Sprague-Dawley rats.
    Pham D; Jeng AY; Escher E; Sirois P; Battistini B
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S362-6. PubMed ID: 11078421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of endothelin-converting enzyme from endothelial cells and rat brain: detection of the formation of biologically active endothelin-1 by rapid bioassay.
    Warner TD; Mitchell JA; D'Orleans-Juste P; Ishii K; Förstermann U; Murad F
    Mol Pharmacol; 1992 Feb; 41(2):399-403. PubMed ID: 1311412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S 17162 is a novel selective inhibitor of big ET-1 responses in the rat.
    Descombes JJ; Mennecier P; Versluys D; Barou V; de Nanteuil G; Laubie M; Verbeuren TJ
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S61-4. PubMed ID: 8587469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A rapid and selective endothelin-converting enzyme assay: characterization of a phosphoramidon-sensitive enzyme from guinea pig lung membrane.
    Fawzi AB; Cleven RM; Wright DL
    Anal Biochem; 1994 Nov; 222(2):342-50. PubMed ID: 7864357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of endogenous endothelin-1 in post-ischemic cardiac dysfunction and norepinephrine overflow in rat hearts.
    Tawa M; Fukumoto T; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2008 Sep; 591(1-3):182-8. PubMed ID: 18586023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of neointima formation in an organ culture of human saphenous vein: a comparison of dual endothelin-converting enzyme/neutral endopeptidase and selective neutral endopeptidase inhibition.
    Porter KE; Dickinson T; London NJ
    J Vasc Surg; 2001 Sep; 34(3):548-54. PubMed ID: 11533610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Phe22]-big endothelin-1[19-37]: a new and potent inhibitor of the endothelin-converting enzyme.
    Claing A; Neugebauer W; Yano M; Rae GA; D'Orléans-Juste P
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S72-4. PubMed ID: 8587472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of endothelin, protein kinase C and free radicals in the mechanism of the post-ischemic endothelial dysfunction in guinea-pig hearts.
    Maczewski M; Beresewicz A
    J Mol Cell Cardiol; 2000 Feb; 32(2):297-310. PubMed ID: 10722805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 prevents hypertensive cardiac remodeling in a blood pressure-independent manner.
    Kalk P; Sharkovska Y; Kashina E; von Websky K; Relle K; Pfab T; Alter M; Guillaume P; Provost D; Hoffmann K; Fischer Y; Hocher B
    Hypertension; 2011 Apr; 57(4):755-63. PubMed ID: 21339476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.